Effects of ranolazine on right ventricular function, fluid dynamics, and metabolism in patients with precapillary pulmonary hypertension: insights from a longitudinal, randomized, double-blinded, placebo controlled, multicenter study is a research paper published in Frontiers in Cardiovascular Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 HL124021, HL 122596
American Heart Association
Grant: 18EIA33900027
NHLBI NIH HHS
Grant: R01 HL124021
NHLBI NIH HHS
Grant: R01 HL122596
NHLBI NIH HHS
Grant: R01 HL151228
National Institutes of Health
Grant: 5R01HL122596-04
Iron-Sulfur Deficiency as a Critical Pathogenic Cause of Pulmonary Hypertension
National Institutes of Health
Grant: 5R01HL124021-09
An endothelial-fibroblast axis connecting senescence to amino acid metabolism for control of vascular stiffness in PAH
Gilead Sciences, Inc.
FWCI
2.15
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals